Seoul, South Korea, between 2001 and 2006. Cohort composed of mothers, who visited to prenatal care between 24 and 28 weeks of gestation. The first follow-up examination was carried out when their children were 3 years of age from November 2005 to July 2010. Details of the cohort were reported previously. 20 This study included 449 subjects who underwent at least 2 follow-up examinations. Data were collected at checkups conducted at 3, 5, and 7 years of age from November 2005 to July 2014. Those who participated in the follow up underwent anthropometric measurements, completed questionnaires, and provided blood and urine samples. The Institutional Review Board on Human Subjects at Ewha Woman's University approved the study protocol, and informed consent was obtained from all subjects.
Anthropometric and blood pressure measurements
All anthropometric and BP measurements were performed by well-trained researchers. Heights and weights without shoes and with light clothing were measured to the nearest 0.1 cm or 0.1 kg using a stadiometer and calibrated scale, respectively (DS-102, Dong Sahn Jenix, Seoul, Korea). Body mass index (kg/m 2 ) was calculated as weight divided by height squared.
After the subjects had been seated comfortably for five minutes, BP was measured twice using an automatic blood pressure (BP) monitor (Dinamap Procure 200, GE, Milwaukee, WI) with a BP cuff of a size appropriate for the circumference of the upper left arm. The Pearson's correlation coefficients for 2-repeated measure of BP at each time point showed moderate positive correlation (SBP, 0.59-0.84; diastolic BP (DBP), 0.42-0.64). The average of the 2 measurements was used for statistical analysis.
Assessment of serum uric acid
After an 8-hour overnight fast, blood samples (3 ml EDTA-blood and 5 ml serum) were obtained from subjects by venepuncture. Serum uric acid concentrations were measured using the uricase and peroxidase-coupled reaction method (Equipment: Hitachi Auto-analyser 7600, Fukuoka, Japan) in the Clinical Biochemistry Department of the Seegene Medical Foundation in Seoul, South Korea. The reference range for uric acid was 2.4-7.0 mg/dl.
Statistical analysis
Data analysis was performed using the SAS version 9.3 software package (SAS Institutes, Cary, NC). A descriptive analysis was performed to summarize the general characteristics of the participants. We conducted univariate analysis between potential factors and BP at 3 years of age to explore the confounding factors. As potential confounding factors, we considered parental history of hypertension, low birth weight, duration of breastfeeding, and sodium intake. But, P values of all analysis were >0.2. To assess the effect of uric acid on SBP and DBP, we used a general linear model after adjusting for sex, current height, and body mass index. Results are expressed as adjusted means and 95% confidence intervals (95% CI). A post hoc analysis was performed using Tukey's multiple comparison tests. Additionally, we also analysed the effect of uric acid as tertile level on BP.
To determine the effects of serum uric acid concentrations on BP in childhood, a linear mixed-effects model (PROC MIXED) analysis was conducted. A compound symmetry working correlation structure was selected for the final model. The random effects were estimated in the repeatedmeasures data. A value of P <0.05 based on a 2-tailed test was taken to indicate statistical significance. Table 1 shows the characteristics of the subjects at baseline and the 3 follow-ups. The proportions of males and females were similar. At baseline, 224 (49.9%) of the total 449 participants were male, and 225 (50.1%) were female. At 5 years of age, 108 (52.4%) were male, and 98 (47.6%) were female. At 7 years of age, 87 (49.7%) were male, and 88 (50.3%) were female. The mean body mass indexes were 15.4 ± 1.4, 15.7 ± 1.6, and 16.0 ± 2.1 kg/m 2 at 3, 5, and 7 years of age, respectively. The mean serum uric acid concentrations at 3, 5, Values are means ± SD and percentages. Abbreviation: BMI, body mass index.
RESULTS
and 7 years of age were 3.8 ± 0.8, 4.0 ± 0.7, and 3.9 ± 0.9 mg/dl, respectively. The SBP and DBP at baseline were 94.7 ± 12.2 and 60.8 ± 10.4 mm Hg, respectively. SBP tended to increase with age, whereas DBP was relatively stable. Table 2 shows the relationship between uric acid levels at 3 and 5 years of age and mean SBP and DBP. The subjects were divided into 2 subgroups according to their median serum uric acid level at 3 or 5 years of age. In the adjusted model, the group with a serum uric acid level higher than the median value had significantly increased SBP [96.4 mm Hg (95% CI, 94.7-98.0) vs. 93.3 mm Hg (95% CI, 91.8-94.8); P < 0.01] and DBP [62.3 mm Hg (95% CI, 60.9-63.7) vs. 59.5 mm Hg (95% CI, 58.2-60.8); P < 0.01] at 3 years of age. Children with a uric acid level higher than the median value at 3 or 5 years of age had tended to higher both SBP and DBP at 7 years of age than those in the group with lower uric acid. However, there was no statistical significance.
When analysed stratified by gender, the mean difference of SBP at 7 years of age by uric acid level at 3 and 5 years of age was notable in boys. But, the effect of uric acid on BP was not differed by gender. In addition, when classifying uric acid level into tertile groups, children with the highest tertile have higher mean of SBP and DBP compared to children with the lowest tertile at 3 years old. But, these results were not maintained in BP of subsequent age (data not shown in Tables) .
A mixed-model analysis revealed that serum uric acid concentration at baseline was significantly associated with BP in later life (Table 3) . SBP (β = 1.17; 95% CI, 0.11-2.23; P = 0.03) and DBP (β = 0.87; 95% CI, 0.05-1.69; P = 0.04) increased with increasing uric acid levels at 3 years of age. SBP (β = 1.98; 95% CI, 0.29-3.66; P = 0.02) and DBP (β = 1.36; 95% CI, 0.03-2.68; P = 0.04) were higher in children with uric acid levels higher than the median value compared with in those with levels lower than the median. The group with the higher uric acid levels at 5 years of age has increased SBP than in their counterparts (P = 0.03). Figure 1 shows BP vs. uric acid levels. Eight plots show the SBPs and DBPs of children 3 and 5 years of age with uric acid levels higher and lower than the median value. The highest SBP at 7 years of age (mean SBP, 106.4 mm Hg; 95% CI, 103.1-109.7; P = 0.03) was detected in subjects with high uric acid levels at 3 and 5 years of age. When compared to children who had an elevated serum uric acid level at 3 years of age but a lower level at 5 years of age, this difference was borderline significant according to Tukey's post hoc test (P = 0.07). DBP showed a similar association with uric acid levels (mean highest DBP, 61.4 mm Hg; 95% CI, 58.7-64.1; P = 0.15).
DISCUSSION
This study investigated the effect of serum uric acid levels on longitudinal BP from infancy to childhood. The serum uric acid concentration in very early childhood was found to influence BP in later life. Considering the change of uric acid levels over time, subjects with high uric acid levels at both 3 and 5 years of age had the highest SBP at 7 years of age. On the other hand, children with an elevated serum uric acid level at 3 years of age but a lower level at 5 years of age had a lower SBP compared with the other groups.
Epidemiological and clinical observation studies over the past few decades involving diverse populations have suggested that uric acid is an independent risk factor for hypertension and elevated BP. The Framingham study found that serum uric acid levels were significantly positively associated with changes in SBP and DBP 4 years later. 21 In a recent study of 3,257 adults in Taiwan, serum uric acid levels were an independent predictor of BP progression and incidental hypertension. 22 A systematic review and meta-analysis by Peter et al. suggested that hyperuricemia is associated with an increased risk of incident hypertension, independent of traditional risk factors. Hyperuricemia was associated with an increased risk of incident hypertension (pooled adjusted risk ratio, 1.41; 95% CI, 1.23-1.58). 23 Recent observational studies involving children and adolescents reported a significant relationship between elevated serum uric acid levels in children and the progression of high BP. In a cross-sectional survey of 6,036 subjects aged 12-17 years in the United States, increased serum uric acid levels were associated with elevated BP in healthy adolescents. The group with an elevated serum uric acid level (≥5.5 mg/dl) had a 2.03-fold higher likelihood of having elevated BP compared with those with a serum uric acid level of <5.5 mg/dl (95% CI, 1.38-3.00). 24 A cohort study of 501 children aged 6-18 years by Viazzi et al. reported that uric acid level was directly related to SBP and DBP after adjusting for puberty, gender, and body mass index Z-score. 25 Alper et al. reported that elevated childhood serum uric acid levels are associated with increased BP in childhood, and that this persists into adulthood. 26 An elevated serum uric acid level in the serum of very young children is likely to have been transferred from the maternal circulation in-utero. High levels of serum uric acid or other placental factors in maternal may be transferred into the fetal circulation through the placenta, contributing to intrauterine growth restriction (IUGR) and a reduction in the number of nephrons. 14, 15 Previous studies have shown that intrauterine growth retardation-such as low birth weight or preterm birth-might impair renal development and result in a reduced number of nephrons at birth. [27] [28] [29] [30] In our previous cohort study, we found that preterm birth and a subsequent high rate of postnatal weight gain are risk factors for increased serum uric acid levels in children at 3 years of age. 16 Feig reported that park et al. suggests a novel mechanism for higher BP and increased cardiovascular risk. Figure 1 . Effects of serum uric acid levels at 3 and 5 years of age on blood pressure at 7 years of age. (a) Adjusted mean systolic blood pressure at 7 years of age stratified by serum uric acid levels at 3 and 5 years of age. (b) Adjusted mean diastolic blood pressure at 7 years of age stratified by serum uric acid levels at 3 and 5 years of age. *Adjusted mean with 95% confidence interval was estimated under controlling for sex, height, and body mass index at 7 years of age. **P value obtained from multiple comparison using Tukey's test. An altered intrauterine environment could lead to changes in metabolism that induce vascular changes and/or hypertension as childhood progresses. 31 Bonamy commented our previous study points out a new area of study within the developmental programming of cardiovascular disease. 32 In this study, we have extended the investigation of the effect of serum uric acid level on BP in preschool-aged children. Serum uric acid levels at 3 years of age were associated with a high BP in later life (P < 0.05). These data confirm that serum uric acid levels during very early childhood are important for maintaining an adequate BP. Moreover, children with elevated serum uric acid levels at 5 years of age had an increased risk of an elevated SBP at 7 years of age. Therefore, serum uric acid levels in early childhood impact BP in later life.
Longitudinal studies conducted in the past few decades have tracked BP from childhood to adulthood in diverse populations. 33, 34 Systematic review of data from diverse populations suggested moderate BP tracking between childhood and adulthood. 12 These findings suggests that BP in early life is associated with that in later life and underscore the importance of adequate BP control beginning in infancy.
In the correlation analysis, serum uric acid levels at 3 years of age were associated with those at 5 and 7 years of age (n = 206, Pearson's r = 0.33, P < 0.0001 at 5 years of age; n = 175, Pearson's r = 0.20, P < 0.01 at 7 years of age). There was a significant positive linear correlation between serum uric acid levels at 5 and 7 years of age (n = 122, Pearson r = 0.45, P < 0.0001; data not shown in Tables). These results suggest that there is significant evidence for tracking uric acid from childhood into preadolescence. However, the level of exposure can change over time. In our analysis, we found that serum uric acid levels at 3 and 5 years of age had a combined effect on SBP at 7 years of age. The most vulnerable children were those with uric acid levels higher than the median value at 3 and 5 years of age. This indicates that an elevated uric acid level at both 3 and 5 years of age results in a greater risk of increased BP in early childhood. Children who had a serum uric acid level greater than the median value at 3 years of age but a lower level than the median at 5 years of age had a significantly lower SBP at 7 years of age compared with those with elevated serum uric acid levels at both 3 and 5 years of age (Tukey's post hoc test; P = 0.07). Although further research is needed, these findings suggest that changes in serum uric acid levels affect BP in childhood.
This study had the following limitations. The relatively small sample size may have limited the statistical power and may have resulted in selection bias, as participants were from a single university hospital. Reduced sample size due to follow-up loss would have contributed to a reduction in reliability and statistical power. Therefore, further studies are warranted to validate our findings in large sample size and to suggest appropriate interventions for maintaining serum uric acid levels and a normal BP in childhood. This study also had several strengths. To our knowledge, this is the first study of the effect of changing serum uric acid on BP during early childhood. Additionally, the baseline serum uric acid concentration was significantly associated with later BP at a relatively early age. These data are available for use in future follow-up studies that aim to identify causal relationships.
The present study suggests the necessity of identifying high-risk individuals in infancy and of intervening appropriately. Serum uric acid levels should be appropriately controlled to maintain adequate BP levels in children and thereby prevent the development of hypertension in adults. Monitoring of the serum uric acid levels in highrisk children may prevent the development of hypertension later in life.
